The company, which has received a grant from the SPRI Group for cybersecurity, develops a one-of-a-kind product: synthetic DNA for application in advanced therapies and personalized medicine.
The company, which has received a grant from the SPRI Group for cybersecurity, develops a one-of-a-kind product: synthetic DNA for application in advanced therapies and personalized medicine.